Innovation: Expanding Access to Medical Breakthroughs

Advances in biotechnology, medical devices, digital health, and artificial intelligence are rapidly transforming healthcare. These breakthroughs offer new possibilities for diagnosing disease earlier, treating complex conditions, and improving patient outcomes.

However, patients can only benefit from innovation when healthcare systems, regulatory frameworks, and insurance policies keep pace with scientific progress.

Patients Rising supports policies that encourage responsible innovation while ensuring new therapies, technologies, and treatments reach the patients who need them most.

Regulatory frameworks must keep pace with scientific advancement so innovative therapies can reach patients safely and efficiently. As new technologies such as gene therapies, precision medicine, and digital health tools emerge, regulatory processes should adapt to ensure patients can benefit from medical breakthroughs without unnecessary delays.

Patients should have access to breakthrough therapies without being restricted by discriminatory evaluation models. Patients Rising supports policies that prevent the use of tools such as Quality Adjusted Life Years (QALYs) that can undervalue treatments for people with disabilities, chronic illness, or rare disease.

Policies should support the development and timely availability of emerging treatments such as gene therapies, precision medicine, and other medical breakthroughs.

Encouraging research and development for rare diseases helps ensure patients with uncommon conditions have access to life-changing therapies.

Emerging technologies can improve diagnosis, expand access to care, and increase efficiency across the healthcare system when implemented responsibly.